Vis enkel innførsel

dc.contributor.authorInfanti, Jennifer
dc.contributor.authorO'Dea, Angela
dc.contributor.authorGibson, Irene
dc.contributor.authorMcGuire, Brian E.
dc.contributor.authorNewell, John
dc.contributor.authorGlynn, Liam G.
dc.contributor.authorO'Neill, Ciaran
dc.contributor.authorConnolly, Susan B.
dc.contributor.authorDunne, Fidelma P.
dc.date.accessioned2019-11-04T12:05:48Z
dc.date.available2019-11-04T12:05:48Z
dc.date.created2014-02-03T14:12:47Z
dc.date.issued2014
dc.identifier.citationBMC Medical Research Methodology. 2014, 14 (13), .nb_NO
dc.identifier.issn1471-2288
dc.identifier.urihttp://hdl.handle.net/11250/2626380
dc.description.abstractBackground Gestational diabetes mellitus (GDM) is a risk factor for the development of type 2 diabetes. Lifestyle intervention can prevent progression to type 2 diabetes in high risk populations. We designed a randomised controlled trial (RCT) to evaluate the effectiveness of an established lifestyle intervention compared to standard care for delaying diabetes onset in European women with recent GDM. Recruitment into the RCT was more challenging than anticipated with only 89 of 410 (22%) women agreeing to participate. This paper identifies factors that could enhance participation of the target population in future interventions. Methods We hypothesised that women who agreed to participate would have higher diabetes risk profiles than those who declined, and secondly that it would be possible to predict participation on the bases of those risk factors. To test our hypothesis, we identified the subset of women for whom we had comprehensive data on diabetes risks factors 3-5?years following GDM, reducing the sample to 43 participants and 73 decliners. We considered established diabetes risk factors: smoking, daily fruit and vegetable intake, participation in exercise, family history of diabetes, glucose values and BMI scores on post-partum re-screens, use of insulin during pregnancy, and age at delivery. We also analysed narrative data from 156 decliners to further understand barriers to and facilitators of participation. Results Two factors differentiated participants and decliners: age at delivery (with women older than 34 years being more likely to participate) and insulin use during pregnancy (with women requiring the use of insulin in pregnancy less likely to participate). Binary logistic regression confirmed that insulin use negatively affected the odds of participation. The most significant barriers to participation included the accessibility, affordability and practicality of the intervention. Conclusions Women with recent GDM face multiple barriers to lifestyle change. Intervention designers should consider: (i) the practicalities of participation for this population, (ii) research designs that capitalise on motivational differences between participants, (iii) alleviating concerns about long-term diabetes management. We hope this work will support future researchers in developing interventions that are more relevant, effective and successful in recruiting the desired population. Trial registration Current Controlled Trials ISRCTN41202110nb_NO
dc.language.isoengnb_NO
dc.publisherBMC (part of Springer Nature)nb_NO
dc.relation.urihttp://www.biomedcentral.com/1471-2288/14/13
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleReasons for participation and non-participation in a diabetes prevention trial among women with prior gestational diabetes mellitusnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.subject.nsiVDP::Samfunnsvitenskap: 200nb_NO
dc.subject.nsiVDP::Social sciences: 200nb_NO
dc.source.pagenumber22nb_NO
dc.source.volume14nb_NO
dc.source.journalBMC Medical Research Methodologynb_NO
dc.source.issue13nb_NO
dc.identifier.doi10.1186/1471-2288-14-13
dc.identifier.cristin1108611
dc.description.localcode© 2014 Infanti et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.nb_NO
cristin.unitcode194,65,20,0
cristin.unitnameInstitutt for samfunnsmedisin og sykepleie
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal